Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women

Gynecological Endocrinology

Volumn 28, Issue 6, 2012, Pages 472-477

  Lee, Suk Woo ^a   Jo, Hyun Hee ^a   Kim, Mee Ran ^a   You, Young Oak ^a   Kim, Jang Heub ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Insulin resistance; Menopause; Osteocalcin; Visceral obesity

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; LIPID; OSTEOCALCIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; METABOLIC RISK; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; WAIST HIP RATIO;

BLOOD GLUCOSE; BODY FAT DISTRIBUTION; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OSTEOCALCIN; POSTMENOPAUSE; RETROSPECTIVE STUDIES; RISK FACTORS; WAIST-HIP RATIO;

EID: 84861018152     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.633660     Document Type: Article

References (32)

1. Teede HJ, Lombard C, Deeks AA. Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric 2010;13:203-209.
2. Tremblay AJ, Despres JP, Piche ME, Nadeau A, Bergeron J, Almeras N, Tremblay A, Lemieux S. Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism 2004;53:310-317. (Pubitemid 38684690)
3. Kawai M, Devlin MJ, Rosen CJ. Fat targets for skeletal health. Nat Rev Rheumatol 2009;5:365-372.
4. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006;2:35-43. (Pubitemid 43153647)
5. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207. (Pubitemid 30064908)
6. Lian JB, Gundberg CM. Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res 1988:267-291.
7. Puchacz E, Lian JB, Stein GS, Wozney J, Huebner K, Croce C. Chromosomal localization of the human osteocalcin gene. Endocrinology 1989;124:2648-2650. (Pubitemid 19132073)
8. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456-469. (Pubitemid 47208519)
9. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008;105:5266-5270. (Pubitemid 351738545)
10. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, Faugere MC, Aja S, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010;142:309-319.
11. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010;142:296-308.
12. Saleem U, Mosley TH, Jr., Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010;30:1474-1478.
13. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009;94:827-832.
14. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
15. Lindheim SR, Buchanan TA, Duffy DM, Vijod MA, Kojima T, Stanczyk FZ, Lobo RA. Comparison of estimates of insulin sensitivity in preand postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc GynecolInvestig 1994;1:150-154. (Pubitemid 2107006)
16. Patel SM, Iqbal N, Kaul S, Ratcliffe SJ, Rickels MR, Reilly MP, Scattergood T, Basu A, et al. Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial. Fertil Steril 2010;94:2161-2166.
17. Nasu M, Sugimoto T, Chihara M, Hiraumi M, Kurimoto F, Chihara K. Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: relationship with bone mineral density and lipid metabolism in perimenopausal women. Eur J Endocrinol 1997;136:608-616. (Pubitemid 27286547)
18. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 1993;8:567-573. (Pubitemid 23127916)
19. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998;78:783-809. (Pubitemid 28340604)
20. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113:846-855. (Pubitemid 38544143)
21. Petzel M. Action of leptin on bone and its relationship to menopause. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:195-199.
22. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiationduring formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-430.
23. Benayahu D, Shamay A, Wientroub S. Osteocalcin (BGP), gene expression, and protein production by marrow stromal adipocytes. Biochem Biophys Res Commun 1997;231:442-446. (Pubitemid 27214330)
24. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-452. (Pubitemid 26264860)
25. Liu SZ, Tian LF, Xu P, Zhuang GH, Zheng F, Tian J, Ning QL, Zhu BF, et al. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women. Mol Biol Rep 2011;38:939-948.
26. Scheven BA, Milne JS. Dehydroepiandrosterone (DHEA) and DHEA-S interact with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to stimulatehuman osteoblastic cell differentiation. Life Sci 1998;62:59-68. (Pubitemid 28132974)
27. Nabipour I, Larijani B, Beigi S, Jafari SM, Amiri M, Assadi M, Pazoki R, Amiri Z, et al. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study. Menopause 2008;15:934-939.
28. Diamanti-Kandarakis E, Livadas S, Katsikis I, Piperi C, Aimilia M, Papavassiliou AG, Panidis D. Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome. J Bone Miner Metab 2011;29: 201-206.
29. Garcia-Martin A, Cortes-Berdonces M, Luque-Fernandez I, Rozas- Moreno P, Quesada-Charneco M, Munoz-Torres M. Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause 2011;18:537-541.
30. Usui C, Asaka M, Kawano H, Aoyama T, Ishijima T, Sakamoto S, Higuchi M. Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people. J Nutr Sci Vitaminol (Tokyo) 2010;56:109-116.
31. Hanley AJ, Karter AJ, Festa A, D'Agostino R, Jr., Wagenknecht LE, Savage P, Tracy RP, Saad MF, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:2642-2647. (Pubitemid 34827418)
32. Nagai M, Komiya H, Mori Y, Ohta T, Kasahara Y, Ikeda Y. Estimating visceral fat area by multifrequency bioelectrical impedance. DiabetesCare 2010;33:1077-1079.